Close

Galena Biopharma (GALE) Bullish Stance Reiterated at Oppenheimer

January 22, 2016 9:51 AM EST Send to a Friend
Oppenheimer analyst Ling Wang reiterated an Outperform rating and $4 price target on Galena Biopharma (NASDAQ: GALE) after the company ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login